罕见病生物标志物 2.0.
Biomarkers in Rare Diseases 2.0.
机构信息
Molecular and Clinical Sciences Research Institute, St. George's, University of London, London SW17 0RE, UK.
出版信息
Int J Mol Sci. 2022 Apr 21;23(9):4582. doi: 10.3390/ijms23094582.
Abstract
It is estimated that there are over 7000 rare diseases, collectively affecting more than 350 million individuals worldwide [...].
摘要
据估计，有超过 7000 种罕见病，全球共有超过 3.5 亿人受其影响[...]。
相似文献
1
Biomarkers in Rare Diseases 2.0.罕见病生物标志物 2.0.
Int J Mol Sci. 2022 Apr 21;23(9):4582. doi: 10.3390/ijms23094582.
2
Biomarkers in Rare Diseases.罕见病的生物标志物。
Int J Mol Sci. 2021 Jan 12;22(2):673. doi: 10.3390/ijms22020673.
3
[Understanding the diagnostic delay in rare diseases].[了解罕见病的诊断延迟]
Ned Tijdschr Geneeskd. 2020 Apr 30;164:D4157.
4
Towards efficiency in rare disease research: what is distinctive and important?面向罕见病研究的效率：有哪些独特和重要的方面？
Sci China Life Sci. 2017 Jul;60(7):686-691. doi: 10.1007/s11427-017-9099-3. Epub 2017 Jun 16.
5
Expediting rare disease diagnosis: a call to bridge the gap between clinical and functional genomics.加速罕见病诊断：呼吁弥合临床与功能基因组学之间的差距。
Mol Med. 2020 Nov 25;26(1):117. doi: 10.1186/s10020-020-00244-5.
6
Accessing the accelerated approval pathway for rare disease therapeutics.获取罕见病治疗药物的加速批准途径。
Nat Biotechnol. 2016 Apr;34(4):380-3. doi: 10.1038/nbt.3530.
7
Biomarkers in rare diseases.罕见病中的生物标志物。
Public Health Genomics. 2013;16(6):313-21. doi: 10.1159/000355938. Epub 2014 Feb 3.
8
Changing the conversation regarding pediatric cholesterol screening: the rare disease paradigm.改变关于儿童胆固醇筛查的话题：罕见病模式。
Arch Pediatr Adolesc Med. 2012 Dec;166(12):1097-8. doi: 10.1001/archpediatrics.2012.1907.
9
Diagnostic needs for rare diseases and shared prediagnostic phenomena: Results of a German-wide expert Delphi survey.罕见病的诊断需求及共同的诊断前现象：一项全德专家德尔菲调查的结果
PLoS One. 2017 Feb 24;12(2):e0172532. doi: 10.1371/journal.pone.0172532. eCollection 2017.
10
Primary cardiac sarcoma: a rare disease with rapid progression.原发性心脏肉瘤：一种进展迅速的罕见疾病。
Eur Heart J. 2015 Mar 14;36(11):698. doi: 10.1093/eurheartj/ehu431. Epub 2014 Dec 10.
引用本文的文献
1
A framework for N-of-1 trials of individualized gene-targeted therapies for genetic diseases.用于遗传疾病个体化基因靶向治疗的 N-of-1 试验框架。
Nat Commun. 2024 Nov 12;15(1):9802. doi: 10.1038/s41467-024-54077-5.
2
Analysis by TeloView Technology Predicts the Response of Hodgkin's Lymphoma to First-Line ABVD Therapy.采用TeloView技术进行的分析预测霍奇金淋巴瘤对一线ABVD疗法的反应。
Cancers (Basel). 2024 Aug 10;16(16):2816. doi: 10.3390/cancers16162816.
本文引用的文献
1
Current Status of Biomarkers in Anti-N-Methyl-D-Aspartate Receptor Encephalitis.抗 N-甲基-D-天冬氨酸受体脑炎相关生物标志物的研究现状
Int J Mol Sci. 2021 Dec 4;22(23):13127. doi: 10.3390/ijms222313127.
2
Biomarkers in AL Amyloidosis.AL 淀粉样变中的生物标志物。
Int J Mol Sci. 2021 Oct 9;22(20):10916. doi: 10.3390/ijms222010916.
3
Biomarkers for Ehlers-Danlos Syndromes: There Is a Role?Ehlers-Danlos 综合征的生物标志物：有作用吗？
Int J Mol Sci. 2021 Sep 20;22(18):10149. doi: 10.3390/ijms221810149.
4
Biomolecular Markers of Recurrent Implantation Failure-A Review.复发性着床失败的生物标志物研究进展。
Int J Mol Sci. 2021 Sep 18;22(18):10082. doi: 10.3390/ijms221810082.
5
Laboratory Investigation of Hybrid IgG4 k/λ in MuSK Positive Myasthenia Gravis.实验室研究 MuSK 阳性重症肌无力中的混合 IgG4 k/λ。
Int J Mol Sci. 2021 Aug 24;22(17):9142. doi: 10.3390/ijms22179142.
6
Th17-Related Cytokines as Potential Discriminatory Markers between Neuromyelitis Optica (Devic's Disease) and Multiple Sclerosis-A Review.Th17 相关细胞因子作为视神经脊髓炎（Devic 病）和多发性硬化症之间的潜在鉴别标志物——综述。
Int J Mol Sci. 2021 Aug 20;22(16):8946. doi: 10.3390/ijms22168946.
7
Objective and Measurable Biomarkers in Chronic Subjective Tinnitus.慢性主观性耳鸣的客观可衡量生物标志物。
Int J Mol Sci. 2021 Jun 21;22(12):6619. doi: 10.3390/ijms22126619.
8
Plasma Gelsolin Reinforces the Diagnostic Value of FGF-21 and GDF-15 for Mitochondrial Disorders.血浆凝溶胶蛋白增强了 FGF-21 和 GDF-15 对线粒体疾病的诊断价值。
Int J Mol Sci. 2021 Jun 15;22(12):6396. doi: 10.3390/ijms22126396.
9
Mesenchymal and Proneural Subtypes of Glioblastoma Disclose Branching Based on GSC Associated Signature.胶质母细胞瘤的间质和神经前体细胞亚型揭示了基于 GSC 相关特征的分支。
Int J Mol Sci. 2021 May 7;22(9):4964. doi: 10.3390/ijms22094964.
10
Biomarkers in Glycogen Storage Diseases: An Update.糖原贮积病中的生物标志物：最新进展
Int J Mol Sci. 2021 Apr 22;22(9):4381. doi: 10.3390/ijms22094381.
Zotero 插件